Cystatin C levels were inversely correlated with the HINE-2 scores.<h4>Conclusion</h4>CCR is a promising biomarker in paediatric SMA patients receiving nusinersen monotherapy; however, its validity and generalizability require confirmation in larger, more diverse multicenter cohorts. Here, CST3 is linked to proximal spinal muscular atrophy.